CINECA IRIS Institutional Research Information System

CERAVOLO, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.463
AS - Asia 12.403
EU - Europa 9.762
SA - Sud America 1.882
Continente sconosciuto - Info sul continente non disponibili 672
AF - Africa 552
OC - Oceania 41
Totale 50.775
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.757
SG - Singapore 3.878
CN - Cina 3.557
IT - Italia 3.376
HK - Hong Kong 2.076
BR - Brasile 1.532
SE - Svezia 1.447
VN - Vietnam 1.050
DE - Germania 988
BG - Bulgaria 774
GB - Regno Unito 561
CA - Canada 512
FR - Francia 491
FI - Finlandia 442
RU - Federazione Russa 401
TR - Turchia 394
AT - Austria 353
IN - India 295
UA - Ucraina 294
KR - Corea 292
JP - Giappone 242
CI - Costa d'Avorio 187
CH - Svizzera 142
BD - Bangladesh 120
AR - Argentina 116
NL - Olanda 113
PL - Polonia 101
MX - Messico 96
IQ - Iraq 84
ES - Italia 80
ZA - Sudafrica 79
SN - Senegal 72
MA - Marocco 58
NG - Nigeria 50
EC - Ecuador 47
PK - Pakistan 46
ID - Indonesia 44
UZ - Uzbekistan 44
VE - Venezuela 41
AU - Australia 38
SA - Arabia Saudita 38
CO - Colombia 37
BE - Belgio 33
CL - Cile 30
IE - Irlanda 30
JO - Giordania 30
LT - Lituania 30
KE - Kenya 29
PY - Paraguay 26
CZ - Repubblica Ceca 25
EG - Egitto 21
PH - Filippine 21
MY - Malesia 20
PE - Perù 20
UY - Uruguay 18
IL - Israele 17
AE - Emirati Arabi Uniti 16
AZ - Azerbaigian 16
JM - Giamaica 16
NP - Nepal 15
CR - Costa Rica 12
DZ - Algeria 12
BJ - Benin 11
BO - Bolivia 11
EU - Europa 11
HN - Honduras 11
TW - Taiwan 11
KG - Kirghizistan 10
KZ - Kazakistan 10
LB - Libano 10
OM - Oman 10
PA - Panama 10
AL - Albania 9
DO - Repubblica Dominicana 9
GT - Guatemala 9
PT - Portogallo 9
TN - Tunisia 9
GR - Grecia 8
IR - Iran 8
EE - Estonia 7
ET - Etiopia 7
GE - Georgia 7
LV - Lettonia 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
AM - Armenia 6
HU - Ungheria 5
PS - Palestinian Territory 5
RO - Romania 5
RS - Serbia 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
CY - Cipro 4
DK - Danimarca 4
GA - Gabon 4
KW - Kuwait 4
LK - Sri Lanka 4
BB - Barbados 3
BH - Bahrain 3
BN - Brunei Darussalam 3
Totale 50.053
Salva come PNG Salva come JPEG
Città #
Ashburn 2.770
Singapore 2.126
Hong Kong 2.055
Woodbridge 1.952
Fairfield 1.862
Dallas 1.524
San Jose 1.514
Houston 1.349
Ann Arbor 1.348
Chandler 1.255
Santa Clara 1.068
Shanghai 924
Milan 893
Seattle 817
Sofia 771
Wilmington 694
New York 625
Cambridge 583
Beijing 572
Serra 525
Boardman 452
Los Angeles 414
Jacksonville 398
Hefei 392
Princeton 381
Ottawa 368
Vienna 313
Lawrence 300
Lauterbourg 289
Seoul 281
Medford 278
Ho Chi Minh City 274
Council Bluffs 266
Munich 262
Tokyo 218
Frankfurt am Main 217
Pisa 203
Florence 196
Izmir 193
Nanjing 191
Abidjan 187
Des Moines 182
Hanoi 168
Buffalo 163
Dearborn 154
London 129
Istanbul 128
Redondo Beach 126
São Paulo 125
Rome 123
Bern 113
Turku 113
Dong Ket 112
Helsinki 109
San Diego 102
Chicago 93
Nanchang 79
Warsaw 76
Bremen 74
Dakar 72
Jüchen 67
Redwood City 65
Orem 61
Norwalk 60
Lancaster 59
Guangzhou 58
Ogden 58
Shenyang 56
Columbus 54
Kunming 53
Lagos 48
Lucca 48
Chennai 47
Nuremberg 47
Baghdad 46
The Dalles 46
Hebei 44
Fuzhou 43
San Francisco 43
Brooklyn 40
Changsha 40
Düsseldorf 40
Johannesburg 40
Montreal 40
Phoenix 40
Tashkent 40
Atlanta 38
Denver 38
Paris 38
Pune 38
Belo Horizonte 37
Da Nang 36
Toronto 34
Mexico City 33
Brussels 32
Rio de Janeiro 32
Quanzhou 31
Tianjin 31
Casablanca 30
Haiphong 30
Totale 35.302
Salva come PNG Salva come JPEG
Nome #
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 391
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: new imaging frontiers 382
Cataract surgery under topical anesthesia in a patient with Parkinson disease and deep brain stimulation: a report of feasibility. 294
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 273
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 273
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 271
Serotonin and neurodegeneration: a preliminary study of platelet serotonin transporter (SERT) in patients with Huntington's disease 257
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 248
Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistance 244
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 236
Disfunzioni sessuali nel morbo di Parkinson: review 232
Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings (Neurological Sciences, (2017), 38, 5, (819-825), 10.1007/s10072-017-2839-3) 232
Gait dynamics in Pisa syndrome and Camptocormia: the role of stride length and hip kinematics 230
The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects 228
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 224
Aerobic rehabilitation program for improving muscle function in Parkinson's disease 221
The precuneus-a witness for excessive aβ gathering in alzheimer's disease pathology 220
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 220
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 217
Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation. 216
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease 214
Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals 212
A case of pelvic floor myoclonic jerk syndrome. 212
Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. 212
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study 211
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 211
Social Cognition and Oxytocin in Huntington’s Disease: New Insights 211
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 206
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 206
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 206
Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study 205
Efficacy of a combined therapeutic approach in the management of Pisa Syndrome 205
Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. 204
The hOGG1 Ser326Cys polymorphism and Huntington's disease 201
Leadless cardiac pacemaker implant in a patient with two deep brain stimulators: a peaceful cohabitation beyond prejudices 200
Mitochondrial DNA single deletion in a patient with postural tremor. 194
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease 193
Bipolar Spectrum disorders in Parkinson's disease: a systematic evaluation 192
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 191
Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease 186
Evolution of clinical features in possible DLB depending on FP-CIT SPECT result 186
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 185
A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. 184
Antipsychotic drugs in Huntington's disease 184
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study. 183
Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease. 183
Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology. 182
Depressive symptoms in Parkinson's disease 181
No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease 181
Oxidative stress assessment in Alzheimer's disease: a clinic setting study 180
Acute and chronic effects of clozapine in essential tremor 179
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 179
Postural Abnormalities in Parkinson's Disease: An Epidemiological and Clinical Multicenter Study 179
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 176
Expanding the clinical phenotype of DYT5 mutations: is multiple system atrophy a possible one? 175
Antioxidants in the Diet and Cognitive Function: Which Role for the Mediterranean Life-style? 175
Involvement of the Nigrostriatal Pathway in Patients With Idiopathic Normal Pressure Hydrocephalus and Parkinsonism 174
Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. 174
Psychosis associated to Parkinson's disease in the early stages: Relevance of cognitive decline and depression 173
Morphometric and functional MRI changes in essential tremor with and without resting tremore. 172
SSRIs do not worsen Parkinson's disease: Evidence from an open-label, prospective study 171
The Italian Dystonia Registry: rationale, design and preliminary findings 171
Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers 171
Long-term beneficial impact of the randomised trial 'Train the Brain', a motor/cognitive intervention in mild cognitive impairment people: effects at the 14-month follow-up 170
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 170
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 170
Correlation between vestibular abnormalities and MRI findings in cerebellar ataxia 169
Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study 169
Myopathic involvement in two cases of Hallervorden-Spatz disease 168
Mild cognitive impairment in De Novo Parkinson's disease according to movement disorder guidelines. 168
Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson's disease patients 168
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 168
Spectrum of addictions in Parkinson's disease: from dopamine dysregulation syndrome to impulse control disorders 166
Decision making in de novo Parkinson's disease 166
Clinical variables associated with treatment changes in Parkinson's disease: results from the longitudinal phase of the REASON study. 166
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study. 165
Event-based prospective memory in newly diagnosed, drug-naive Parkinson's disease patients 164
Non-motor symptoms in atypical and secondary parkinsonism: The PRIAMO study 164
Comparison of plasmatic interleukins patterns among cognitively unimpaired subjects, patients affected by mild cognitive impairment and subjects with Alzheimer's disease dementia 162
Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky Medical Adherence Scale-8 items". 162
Apomorphine hydrochloride for the treatment of Parkinson's disease. 162
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases 162
Association between amantadine and the onset of dementia in Parkinson's disease 161
Automated MRI Classification in Progressive Supranuclear Palsy: a Large International Cohort Study 161
Prevalence and clinical correlates of comorbid anxiety and panic disorders in patients with Parkinson’s disease 160
Quantitative susceptibility mapping in atypical Parkinsonisms 159
Evaluating the SERCA2 and VEGF mRNAs as potential molecular biomarkers of the onset and progression in huntington's disease 159
Dissecting the Interplay between Time of Dementia and Cognitive Profiles in Lewy Body Dementias 159
Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy 158
The mtDNA A8344G "MERRF" mutation is not a common cause of sporadic Parkinson disease in Italian population 158
The association between motor subtypes and alexithymia in de novo Parkinson's disease. 157
Iowa Gambling Task in de novo Parkinson's disease: a comparison between good and poor performers 157
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging 157
Symptomatic orthostatic tremor associated with Graves' disease. 156
Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis 156
Predictive value of nigrostriatal dysfunction in isolated tremor: A clinical and SPECT study 155
Clinical/scientific notes 155
Sindrome da encefalopatia posteriore reversibile (PRES) in una paziente psoriasica in trattamento con ciclosporina 154
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire 154
Unilateral periodic limb movements: is this a pointer for atypical presentation of corticobasal degeneration syndrome?--A case report 154
Totale 19.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 148.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.283 0 125 71 254 657 440 91 176 199 99 225 946
2022/20234.283 563 536 340 356 460 539 37 309 760 23 280 80
2023/20243.850 454 412 406 318 561 764 139 134 30 68 178 386
2024/202510.919 115 416 176 569 789 953 1.074 511 1.158 1.562 1.371 2.225
2025/202613.378 949 1.621 1.732 1.225 1.406 1.135 2.034 620 710 1.207 450 289
2026/2027709 403 306 0 0 0 0 0 0 0 0 0 0
Totale 50.775